Development of type II diabetes after combined kidney-pancreas transplantation in a patient with type I (insulin-dependent) diabetes.
Wadström
J
J
Department of Internal Medicine, Västerås Hospital, Sweden.
Gannedahl
G
G
Wahlberg
J
J
Frödin
L
L
Tedbrandt
A
A
Berne
C
C
D000328:Adult; D000681:Amylases / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000601:surgery*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000209:etiology*; D003928:Diabetic Nephropathies / Q000097:blood / Q000601:surgery*; D005215:Fasting; D005260:Female; D005500:Follow-Up Studies; D015309:Glucose Clamp Technique; D006442:Glycated Hemoglobin / Q000032:analysis; D006084:Graft Rejection; D006801:Humans; D007328:Insulin / Q000097:blood; D007330:Insulin Antibodies / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology; D016035:Pancreas Transplantation / Q000502:physiology; D011384:Proinsulin / Q000097:blood; D013997:Time Factors
D000681:Amylases; D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin; D007328:Insulin; D007330:Insulin Antibodies; D011384:Proinsulin